PK and Safety of Beclomethasone Dipropionate via Breath-Actuated Inhaler and Metered-Dose Inhaler

Study Title
A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
Teva Identifier
BDB-AS-101
ClinicalTrials.gov Identifier
NCT02030457
Study Status
Completed
Trial Condition(s)
Pharmacokinetics
Interventions
Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 45 Years
Trial Duration
12/01/2013 - 06/01/2014
Phase
Phase 1

Study Type

Interventional